Abstract
Intraductal carcinoma (DCIS) was once an uncommon disease. Today, DCIS represents 20-30% of breast cancers that are diagnosed. Mammography has been the gold standard in detecting DCIS, however recent evidence demonstrates that magnetic resonance imaging (MRI) may be superior to mammography in detecting DCIS. In addition, MRI may be able to detect high grade, mammographically occult DCIS that are more likely to progress on to become invasive carcinoma.
Keywords: Breast Cancer, DCIS, Detection, Mammography, MRI
Current Cancer Therapy Reviews
Title:Imaging Intraductal Carcinoma
Volume: 8 Issue: 3
Author(s): Susan Weinstein
Affiliation:
Keywords: Breast Cancer, DCIS, Detection, Mammography, MRI
Abstract: Intraductal carcinoma (DCIS) was once an uncommon disease. Today, DCIS represents 20-30% of breast cancers that are diagnosed. Mammography has been the gold standard in detecting DCIS, however recent evidence demonstrates that magnetic resonance imaging (MRI) may be superior to mammography in detecting DCIS. In addition, MRI may be able to detect high grade, mammographically occult DCIS that are more likely to progress on to become invasive carcinoma.
Export Options
About this article
Cite this article as:
Weinstein Susan, Imaging Intraductal Carcinoma, Current Cancer Therapy Reviews 2012; 8 (3) . https://dx.doi.org/10.2174/157339412802653119
DOI https://dx.doi.org/10.2174/157339412802653119 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Current progress in Protein Degradation and Cancer Therapy
argeted Protein Degradation is gaining momentum in cancer therapy, it facilitate targeting undruggable proteins, it overcome cancer resistance and avoid undesirable side effects. Thus small molecules degraders have emerged as novel therapeutic strategy. Targeted protein degradation (TPD), the process of eliminating a protein of interest hold a great promise for ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Protein/ Hormone Based Nanoparticles as Carriers for Drugs Targeting Protein-Protein Interactions
Current Topics in Medicinal Chemistry Signaling Pathways of the ING Proteins in Apoptosis
Current Drug Targets Delineation of Current Development of Antimitotic Compounds Targeting Cytoskeletal Protein Tubulin and Microtubule in the Cancer Therapy
Current Chemical Biology Creating A Standard of Care for Fertility Preservation
Current Women`s Health Reviews Ligands and Therapeutic Perspectives of Adenosine A2A Receptors
Current Pharmaceutical Design Natural Flora and Anticancer Regime: Milestones and Roadmap
Anti-Cancer Agents in Medicinal Chemistry Gender Differences in P-Glycoprotein Expression and Function: Effects on Drug Disposition and Outcome
Current Drug Metabolism The Urokinase Receptor as a Potential Target in Cancer Therapy
Current Pharmaceutical Design The Role of Neurogenesis in Neurodegenerative Diseases and its Implications for Therapeutic Development
CNS & Neurological Disorders - Drug Targets Viral Vectors for Gene-Directed Enzyme Prodrug Therapy
Current Gene Therapy Biologic Therapies in Primary Sjögren's Syndrome
Current Pharmaceutical Biotechnology Structural Effects of TiO2 Nanoparticles and Doxorubicin on DNA and their Antiproliferative Roles in T47D and MCF7 Cells
Anti-Cancer Agents in Medicinal Chemistry The Relationship between Pre-miR-3131 3-bp Insertion/Deletion Polymorphism and Susceptibility and Clinicopathological Characteristics of Patients with Breast Cancer
MicroRNA Targeting the L-Arginine-Nitric Oxide Pathway for Cancer Treatment
Current Pharmaceutical Design Positron Emission Tomography Radiopharmaceuticals for Sex Steroid Hormone Receptor Imaging
Current Medicinal Chemistry Combination of Phytochemicals as Adjuvants for Cancer Therapy
Recent Patents on Anti-Cancer Drug Discovery Editorial [Hot Topic: How Drugs may Work to Better Protect the Gastrointestinal Tract: Mechanisms Involved in Gastrointestinal Tract Protection]
Current Pharmaceutical Design Clonetics
Current Drug Metabolism Current and Emerging Therapies in Neuroendocrine Tumors: Impact of Genetic Targets on Clinical Outcomes
Clinical Cancer Drugs Role of Carboplatin in the Treatment of Triple Negative Early- Stage Breast Cancer
Reviews on Recent Clinical Trials